Inflammation in Parkinson's
Search documents
BioVie Inc. (BIVI) Discusses Clinical Progress of Bezisterim Targeting Inflammation in Parkinson's, Alzheimer's, and Long COVID Transcript
Seeking Alpha· 2026-03-05 08:22
Core Viewpoint - BioVie is actively engaging with investors through a presentation led by its President and CEO, Cuong Do, highlighting the company's strategic direction and future prospects [1]. Company Overview - BioVie trades on NASDAQ under the ticker symbol "BioVie" [1]. - The event is organized by Redchip Companies, indicating a focus on investor relations and market engagement [1]. Future Outlook - The presentation may include forward-looking statements regarding financial and operational results, reflecting management's expectations and strategic goals [1]. - The company acknowledges that these forward-looking statements involve inherent risks and uncertainties, which are typical in the biotech sector [1].